Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. (United States) has no DMF, CEP or site registration linked in our records. 9 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Sumitomo Pharma America, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sumitomo-pharma-america-inc
Overview
Sumitomo Pharma America, Inc. is a pharmaceutical company headquartered in Marlborough, United States.
FDA compliance signals
9 FDA enforcement records linked to this company.
- 4832015-01-23
Late submission of 15-day report
- 4832011-12-09
Contamination, chemical or physical change, deterioration
- 4832011-12-09
Investigations of discrepancies, failures
- 4832011-04-20
Contract drug products--lack of responsibility
- 4832011-04-20
Failure to meet specifications
- 4832010-06-03
Procedures to be written and followed
- 4832010-06-03
Investigations of discrepancies, failures
- 4832009-09-01
Late submission of quarterly safety reports
- 4832009-09-01
Failure to develop written procedures
Is this Sumitomo Pharma America, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.